Sales of weight loss pill likely to be prohibited in Korea

Published: 2010-10-15 07:00:00
Updated: 2010-10-15 07:00:00
The controversial anti-obesity drug sibutramine could be banned in India, according to pharmaceutical sources.

The Korea Food and Drug Administration (KFDA) is coming under criticism for its lax management of controversial sibutramine-based drugs used for weight loss, which have recently been ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.